BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 24462899)

  • 1. Synthesis and therapeutic evaluation of an aptide-docetaxel conjugate targeting tumor-associated fibronectin.
    Kim H; Lee Y; Lee IH; Kim S; Kim D; Saw PE; Lee J; Choi M; Kim YC; Jon S
    J Control Release; 2014 Mar; 178():118-24. PubMed ID: 24462899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vivo antitumor effects of chitosan-conjugated docetaxel after oral administration.
    Lee E; Kim H; Lee IH; Jon S
    J Control Release; 2009 Dec; 140(2):79-85. PubMed ID: 19712714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor targetability and antitumor effect of docetaxel-loaded hydrophobically modified glycol chitosan nanoparticles.
    Hwang HY; Kim IS; Kwon IC; Kim YH
    J Control Release; 2008 May; 128(1):23-31. PubMed ID: 18374444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibody-Assisted Delivery of a Peptide-Drug Conjugate for Targeted Cancer Therapy.
    Kim H; Hwang D; Choi M; Lee S; Kang S; Lee Y; Kim S; Chung J; Jon S
    Mol Pharm; 2019 Jan; 16(1):165-172. PubMed ID: 30521347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.
    Mohammadgholi M; Sadeghzadeh N; Erfani M; Abediankenari S; Abedi SM; Emrarian I; Jafari N; Behzadi R
    Anticancer Agents Med Chem; 2018; 18(2):277-285. PubMed ID: 28925879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeted Cancer Therapy Using Fusion Protein of TNFα and Tumor-Associated Fibronectin-Specific Aptide.
    Jeon H; Kim D; Choi M; Kang S; Kim JY; Kim S; Jon S
    Mol Pharm; 2017 Nov; 14(11):3772-3779. PubMed ID: 28969419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel mixed micelle gel with thermo-sensitive property for the local delivery of docetaxel.
    Yang Y; Wang J; Zhang X; Lu W; Zhang Q
    J Control Release; 2009 Apr; 135(2):175-82. PubMed ID: 19331864
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fibronectin extra domain B-specific aptide conjugated nanoparticles for targeted cancer imaging.
    Park J; Kim S; Saw PE; Lee IH; Yu MK; Kim M; Lee K; Kim YC; Jeong YY; Jon S
    J Control Release; 2012 Oct; 163(2):111-8. PubMed ID: 22964395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The structure of polymer carriers controls the efficacy of the experimental combination treatment of tumors with HPMA copolymer conjugates carrying doxorubicin and docetaxel.
    Šírová M; Strohalm J; Chytil P; Lidický O; Tomala J; Říhová B; Etrych T
    J Control Release; 2017 Jan; 246():1-11. PubMed ID: 27940304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Therapeutic efficacy of lipid emulsions of docetaxel-linoleic acid conjugate in breast cancer.
    Zhang T; Li M; Yang R; Zhang D; Guan J; Yu J; Yang B; Zhang H; Zhang S; Liu D; Wang Y
    Int J Pharm; 2018 Jul; 546(1-2):61-69. PubMed ID: 29763687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Docetaxel-loaded RIPL peptide (IPLVVPLRRRRRRRRC)-conjugated liposomes: Drug release, cytotoxicity, and antitumor efficacy.
    Yoon HY; Kwak SS; Jang MH; Kang MH; Sung SW; Kim CH; Kim SR; Yeom DW; Kang MJ; Choi YW
    Int J Pharm; 2017 May; 523(1):229-237. PubMed ID: 28341149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembled nanoparticles comprising aptide-SN38 conjugates for use in targeted cancer therapy.
    Kim H; Lee Y; Kang S; Choi M; Lee S; Kim S; Gujrati V; Kim J; Jon S
    Nanotechnology; 2016 Dec; 27(48):48LT01. PubMed ID: 27804918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic active targeting of dually integrin αvβ3/CD44-targeted nanoparticles to B16F10 tumors located at different sites of mouse bodies.
    Shi S; Zhou M; Li X; Hu M; Li C; Li M; Sheng F; Li Z; Wu G; Luo M; Cui H; Li Z; Fu R; Xiang M; Xu J; Zhang Q; Lu L
    J Control Release; 2016 Aug; 235():1-13. PubMed ID: 27235150
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra-domain B of fibronectin as an alternative target for drug delivery and a cancer diagnostic and prognostic biomarker for malignant glioma.
    Saw PE; Xu X; Kang BR; Lee J; Lee YS; Kim C; Kim H; Kang SH; Na YJ; Moon HJ; Kim JH; Park YK; Yoon W; Kim JH; Kwon TH; Choi C; Jon S; Chong K
    Theranostics; 2021; 11(2):941-957. PubMed ID: 33391514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEG-PLA nanoparticles modified with APTEDB peptide for enhanced anti-angiogenic and anti-glioma therapy.
    Gu G; Hu Q; Feng X; Gao X; Menglin J; Kang T; Jiang D; Song Q; Chen H; Chen J
    Biomaterials; 2014 Sep; 35(28):8215-26. PubMed ID: 24974009
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.
    Hao Y; Zhang B; Zheng C; Ji R; Ren X; Guo F; Sun S; Shi J; Zhang H; Zhang Z; Wang L; Zhang Y
    J Control Release; 2015 Dec; 220(Pt A):545-555. PubMed ID: 26590021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics and in vitro/in vivo antitumor efficacy of aptamer-targeted Ecoflex
    Ghassami E; Varshosaz J; Jahanian-Najafabadi A; Minaiyan M; Rajabi P; Hayati E
    Int J Nanomedicine; 2018; 13():493-504. PubMed ID: 29416331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design of theranostic nanomedicine (II): synthesis and physicochemical properties of a biocompatible polyphosphazene-docetaxel conjugate.
    Jun YJ; Park JH; Avaji PG; Park KS; Lee KE; Lee HJ; Sohn YS
    Int J Nanomedicine; 2017; 12():5373-5386. PubMed ID: 28794629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-based co-delivery of siRNA and docetaxel for the synergistic treatment of lung cancer.
    Qu MH; Zeng RF; Fang S; Dai QS; Li HP; Long JT
    Int J Pharm; 2014 Oct; 474(1-2):112-22. PubMed ID: 25138252
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time-staggered delivery of docetaxel and H1-S6A,F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting.
    Li L; Sun W; Zhang Z; Huang Y
    J Control Release; 2016 Jun; 232():62-74. PubMed ID: 27098443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.